Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Long-Term Outcomes of Rezūm Therapy for Large-Volume Benign Prostatic Hyperplasia: A Multicenter Cohort Study.

Lower urinary tract symptoms·2026
Same author

Predictors of surgical retreatment following Rezūm water vapor therapy: a multi-center real-world cohort study.

World journal of urology·2026
Same author

Outcomes of Rezūm therapy in young men: A multi-center study.

Urologia·2026
Same author

Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence.

Nature reviews. Urology·2026
Same author

Healthcare disparities and pelvic organ prolapse operative complications: a nationwide analysis.

Gynecology and pelvic medicine·2026
Same author

Health Care Sustainability: Strategies for Operating Rooms and Urogynecologic Procedures.

Urogynecology (Philadelphia, Pa.)·2026

Related Experiment Video

Updated: Jun 2, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

Inflammation and benign prostatic hyperplasia: clinical implications.

Bilal Chughtai1, Richard Lee, Alexis Te

  • 1Department of Urology, Weill Cornell Medical College, New York, USA.

Current Urology Reports
|April 27, 2011
PubMed
Summary
This summary is machine-generated.

Prostatic inflammation is increasingly recognized as a key factor in the development of benign prostatic hyperplasia (BPH). Research highlights how inflammatory processes and cellular interactions drive prostate enlargement and related chronic diseases.

More Related Videos

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

Related Experiment Videos

Last Updated: Jun 2, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

Area of Science:

  • Urology
  • Pathology
  • Immunology

Background:

  • Benign prostatic hyperplasia (BPH) is a common condition in aging men.
  • The role of inflammation in prostate pathobiology is an area of active research.
  • Epithelial and stromal cell interactions are crucial in prostate tissue remodeling.

Purpose of the Study:

  • To review recent international literature on the role of inflammation in BPH progression.
  • To analyze findings supporting inflammation as a driver of benign prostatic hyperplasia.
  • To explore intrinsic and extrinsic factors causing prostatic inflammation.

Main Methods:

  • Systematic review of the international literature.
  • PubMed database search for relevant studies.
  • Analysis of growth factors and cytokines involved in prostatic inflammation and cell interactions.

Main Results:

  • Evidence suggests prostatic inflammation significantly contributes to hyperplastic changes.
  • Specific growth factors and cytokines mediate inflammatory processes in the prostate.
  • Inflammation is implicated in the progression of chronic prostatic diseases like BPH.

Conclusions:

  • Prostatic inflammation is a significant factor in benign prostatic hyperplasia.
  • Understanding inflammatory pathways can offer insights into BPH management.
  • Further research into the causes and effects of prostatic inflammation is warranted.